Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Management of Chronic Kidney Disease Stages 1–3

Slide: 20 of 29

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With Other Interventions

A low-strength body of evidence showed similar results for the risk of all-cause mortality between the following comparators: calcium channel blocker versus placebo; strict versus standard blood pressure-target treatment; gemfibrozil versus placebo; and dietary interventions. The strength of evidence for all comparators is low.